Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Investment
Sort By
Newest First
1 / 11
Samsung Biologics
Investment
Samsung Invests in Generate: Biomedicines to Advance AI-Driven Protein Therapeutics Discovery
Samsung Biologics
PR-12-24-NI-141
Dec 18, 2024
Theravance Biopharma
Announcement
Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 43rd Annual Healthcare Conference
Theravance Biopharma
PR-12-24-NI-137
Dec 17, 2024
Amgen
Announcement
Amgen Announces $1 Billion Manufacturing Expansion in North Carolina
Amgen
PR-12-24-NI-129
Dec 06, 2024
AI
Plan Ahead: Mastering Your AI Budget for 2025 Success
Stephen Tharp
Dotmatics
PAO-10-24-CL-06
Oct 07, 2024
Piramal Pharma Ltd.
Financing
Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky
Piramal Pharma Ltd.
PR-09-24-NI-24
Sep 30, 2024
Vetter Pharma International GmbH
Expansion
Vetter looks ahead to further expansions to meet supply chain demand
Vetter Pharma International GmbH
PR-M10-23-03
Oct 17, 2023
mRNA Manufacturing
Investing in the Future of mRNA Manufacturing
Esther Yoo, Ph.D.
Samsung Biologics
PAO-11-022-CL-02
Nov 16, 2022
Orgenesis
Investment
Orgenesis Secures up to USD 50 Million Subsidiary-Level Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Services
Orgenesis
PR-M11-22-05
Nov 07, 2022
Vetter Pharma International GmbH
Warehouse Storage
New Fully Automated Vetter Warehouse Expands Storage and Boosts Logistical Infrastructure
Vetter Pharma International GmbH
PR-M10-22-07
Oct 27, 2022
MilliporeSigma
Manufacturing Investment
MilliporeSigma Announces Investment of More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France
MilliporeSigma
PR-M09-22-02
Sep 08, 2022
AcuraBio
Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
AcuraBio
PR-M09-22-01
Sep 07, 2022
Olon
New Division
Olon Presents Olon Biotech, A New Division Operating by Biotechnological Processes
Olon
PR-M07-22-03
Jul 12, 2022
Column: M&A
Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.
Nigel Walker
Nice Insight
PAO-06-022--NI-12
Jun 24, 2022
Column: Investment
IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?
Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-02
Jun 24, 2022
Vernal Biosciences
mRNA Manufacturing
Vernal Biosciences Raises $21 Million to Accelerate mRNA Manufacturing Growth
Vernal Biosciences
PR-M06-22-01-351
Jun 02, 2022
uMotif
Decentralized Clinical Trials
uMotif – The Patient-First Data Capture and Decentralized Clinical Trials Platform – Announces $25.5m of New Investment from a Fund Managed by Athyrium Capital Management
uMotif
PR-M05-22-13
May 25, 2022
Immuno-Oncology
Building Multiple Platforms to Address Difficult-to-Treat Cancers
Derek Hennecke
Inceptor Bio
PAO-05-22-R250-09
May 24, 2022
Olon
Spray Drying
Olon Invests in New Spray Dryer at Rodano R&D Centre
Olon
PR-M05-22-11
May 17, 2022
Investment
Bringing Value to Pharma and Biopharma
Commercial Healthcare Partners
PAO-04-22-R250-75
Apr 29, 2022
Investment
Driving Transformational Change in the Middle Market
Excellere Partners
PAO-04-22-R250-65
Apr 14, 2022
1 / 11
